10 November 2020 in The Journal of Vascular Access
Introduction: Central venous accesses devices (CVADs) have a fundamental importance for diagnostic and therapeutic purposes in pediatric onco-hematological patients. The treatment of pediatric onco-hematological diseases is complex and requires the use of integrated multimodal therapies. Long-lasting and safe central venous access is therefore a cornerstone for any successful treatment. Methods: The aim of this work is to define pediatric guidelines about the management of CVADs in onco-hematology. A panel of experts belonging to the working groups on Infections and Supportive Therapy, Surgery and Nursing of the Italian Pediatric Hematology Oncology Association (AIEOP) revised the scientific literature systematically, scored the level of evidence and prepared these guidelines. The content of the following guidelines was approved by the Scientific Board of AIEOP. Results and Conclusions: Important innovations have been developed recently in the field of CVADs, leading to new insertion methods, new materials and new strategy in the overall management of the device, especially in the adult population. These guidelines recommend how to apply these innovations in the pediatric population, and are directed to all physicians, nurses and health personnel active in the daily management of CVADs. Their aim is to update the knowledge on CVAD and improve the standard of care in pediatric patients with malignancies.
31 July 2026 in Dissertation Nursing
GAGruppo di Lavoro Sulle Competenze Aieop
Gruppo di Lavoro Sulle Competenze Aieop
+10
BACKGROUND: Pediatric hemato-oncology is a highly complex clinical field characterized by advanced clinical, relational, and ethical care needs. In Italy, there is currently no formal recognition or national Core Curriculum for the Pediatric Hemato-Oncology Nurse (PHON), resulting in educational and organizational variability. AIMS: To define, through a structured consensus process, a set of advanced competencies aimed at developing a national Core Curriculum and Job Description for PHONs within the Italian healthcare context. METHODS: This methodological study was conducted in two phases: an initial review of national and international literature to identify preliminary competencies, followed by a two-round electronic Delphi process involving nurse representatives from AIEOP centers. Competencies were evaluated for clarity and relevance using a 5-point Likert scale (0–4). Consensus regarding the level of expertise required for professional autonomy (novice, intermediate, expert) was defined as ≥75% agreement. RESULTS: Nineteen nurses participated (mean age 45 years; mean 18 years of experience in pediatric hemato-oncology). Following the first round, textual and structural revisions were implemented. After the second round, a Core Curriculum comprising 126 competencies organized into nine macro-areas was established. Professional autonomy was expected within the first year for 58 competencies, after 1–3 years for 46, and after more than three years for 22 competencies. CONCLUSIONS: The Delphi process enabled the development of a shared national competency framework, providing a methodologically robust foundation for the recognition and advancement of the Pediatric Hemato-Oncology Nurse role in Italy.
25 November 2025 in Journal of Pediatric Hematology/Oncology Nursing
Background: The transition from hospital to home care in pediatric hematology/oncology brings important benefits for families, but it can also generate anxiety regarding the management of symptoms at home. Although hospitals offer 24/7 telephone support, there is currently no standardized telephone triage tool in Italy for pediatric hematology/oncology, resulting in variability in inconsistent practices. This study aims to carry out the linguistic validation in Italian of the “Oncology/Hematology Telephone Triage Toolkit for Children and Young People V2 (2020),” a tool designed to standardize and improve the telephone triage process. Method: After obtaining approval from the tool's authors, the linguistic validation process was developed in 10 steps, according to international guidelines: After forward and backward translation, a preliminary version was created and evaluated through the Item and Scale Content Validity Indices to obtain an Italian version of the tool. Results: The working group of native-speaking professionals and a panel of nine experts from various Italian hematology and oncology institutions reviewed and approved the translation, achieving item content validity scores between 0.8 and 1 and scale content validity scores between 0.88 and 1. Some linguistic adjustments were made to adapt terms to the Italian context while maintaining the original meaning. The final Italian version preserved the original meaning and was deemed conceptually equivalent to the source tool. Discussion: A validated methodology in the translation and validation process successfully adapted the tool to the Italian context, maintaining its content and design. The final Italian version is now ready for usability testing.